Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 49; no. 8; pp. 1124 - 1126
Main Authors Bhamidipati, P K, DiPersio, J F, Stokerl-Goldstein, K, Rashidi, A, Gao, F, Uy, G L, Westervelt, P, Vij, R, Schroeder, M A, Abboud, C N, Keller, J W, Fehniger, T A, Romee, R
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.08.2014
Nature Publishing Group
Subjects
631/250/1904
692/700/565/1436
692/700/565/545/576/1955
Adult
Aged
Allografts
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Bone marrow
Bone marrow, stem cells transplantation. Graft versus host reaction
Cell Biology
Disease-Free Survival
Female
Follow-Up Studies
Granulocyte colony-stimulating factor
Granulocyte Colony-Stimulating Factor - administration & dosage
Hematologic Neoplasms - mortality
Hematologic Neoplasms - therapy
Hematology
Hematopoietic Stem Cell Mobilization
Hematopoietic stem cells
Humans
Internal Medicine
letter-to-the-editor
Lymphocyte Depletion
Lymphocytes T
Male
Medical sciences
Medicine
Medicine & Public Health
Middle Aged
Peripheral Blood Stem Cell Transplantation
Properties
Public Health
Stem cell transplantation
Stem Cells
Survival Rate
Time Factors
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Transplantation
Transplantation Conditioning
United Kingdom
Mobilization
Granulocyte colony stimulating factor
Haploidentical graft
Prognosis
Treatment
Hematology
Surgery
T-Lymphocyte
Transplantation
Non myeloablative treatment
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0268-3369
1476-5365
DOI:10.1038/bmt.2014.108